Puberty development in people with RASopathies
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how puberty develops in people with RASopathies. It aims to understand the process better by studying those who have already completed puberty.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 8 and 35 years old
- You have a confirmed diagnosis of a RASopathy
- You have gone through all stages of puberty
- You can give consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have a RASopathy—a genetic condition—and also have solid tumors (tumor growths not in blood). To join, your RASopathy must be confirmed by genetic testing, not only by symptoms.
This study looks at people with certain inherited genetic conditions called RASopathies and their family members. It helps researchers understand these conditions and how genetic changes run in families, which may improve future care.
This study looks at medical records of children with a genetic condition called RASopathy who developed thickened heart muscle and needed hospital care for heart failure in their first six months of life. The goal is to understand how the heart condition progresses over time.
This study looks at the thyroid (a small gland in your neck that controls energy) in people with RASopathies (genetic conditions like Noonan syndrome). They will use an ultrasound to check the shape and structure of the thyroid and test your thyroid's function.
This study looks at cholesterol and fat levels in people with Noonan syndrome or related conditions. It aims to understand how these levels change with age, gender, and genetic cause.
This study looks at children with central precocious puberty (early puberty that starts in the brain) to see how often it's linked with other developmental issues. It compares how these children develop and respond to treatment.
Hear when a new RASopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.